SWOG clinical trial number
SWOG-7514
VP-16-213 in Adults with Metastatic Adenocarcinoma of the Breast
Closed
Abbreviated Title
VP-16-213 in Adults with Metastatic Adenocarcinoma of the Breast
Activated
08/08/1975
Closed
02/01/1978
Publication Information Expand/Collapse
1982
Phase II evaluation of VP-16-213 in patients with advanced breast cancer
1981
Phase II evaluation of 4-demethyl-E-pipodophyl-lotoxin-B- dethylidone glucoside (VP-16-213) (NSC-14150) in patients with advanced breast cancer: A Southwest Oncology Group study